
Company Info
Year Established2018
Contacts
Daniel CohenCEO & Co-Founder
Company Description
Valence, formerly InVivo AI, and a Recursion company, is unlocking the true potential of deep learning in drug design by unifying best-in-class deep learning technologies with intuitive infrastructure to allow any drug discovery team to become AI-enabled.